Latest News

Novo Nordisk spends big in France to expand obesity drug capacity
Novo Nordisk spends big in France to expand obesity drug capacity
Economy
by  AFP

Danish pharmaceutical giant Novo Nordisk will announce Thursday a major investment in a French production site to expand capacity for a blockbuster anti-obesity drug, the French presidency said. Novo Nordisk already said this month it was investing 42 billion Danish kroner ($6.1 billion) to expand its facilities in Denmark.